亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Scleral Lens Use in the Management of Ocular Cicatricial Pemphigoid

医学 倒睫 睑球粘连 巩膜晶状体 视力 眼科 类天疱疮 隐形眼镜 角膜 外科 眼睑 抗体 免疫学 大疱性类天疱疮
作者
Boris Severinsky,Stephen T. Chambers,Amaan Shafi,Soroosh Behshad,Joung Taek Kim
出处
期刊:Eye & Contact Lens-science and Clinical Practice [Ovid Technologies (Wolters Kluwer)]
卷期号:51 (4): 201-205
标识
DOI:10.1097/icl.0000000000001172
摘要

Purpose: Symptom management in Ocular Cicatricial Pemphigoid (OCP) is challenging because of the progressive factors of dry eye, scarring, trichiasis, and vision impairment. We set out to evaluate the benefits and therapeutic effects of scleral contact lenses in the management of OCP. Methods: A retrospective review was performed over a database of 20 patients (36 eyes) fitted with scleral lenses (SL) at the Department of Ophthalmology, Emory University from May 2018 to April 2021. The fitting indications, time required for ocular surface stabilization, vision rehabilitation success, and ocular complications were evaluated. Results: The mean age was 67.4 (range, 43–81) years, with four to one female to male predominance. The mean duration of the follow-up was 16.5 months (range, 1.5–35). The mean wearing time was 9.0±1.9 hr a day, with no overnight wear permitted. All fitted patients reported a subjective improvement in ocular comfort after initiations of SL wear. The mean keratopathy grading improved from 2.1±0.8 to 1.4±0.7 at the last documented visit. The mean visual acuity improved from 0.56±0.51 (logMAR) to 0.34±0.45; in 46% of patient eyes, visual acuity improved by two or more lines. And 96% of fitted eyes responded well to therapy and continued scleral lens wear. Patients who initially presented with fornix shortening, symblepharon, and trichiasis remained stable. Conclusions: SL offer ocular surface preservation, symptom relief, and improved visual acuity in patients with ocular pemphigoid. They should be strongly considered as ancillary therapy in patients with OCP.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
1秒前
桐桐应助磊磊磊采纳,获得10
3秒前
鲤鱼大神发布了新的文献求助10
5秒前
王欧尼发布了新的文献求助10
5秒前
BOSSJING完成签到,获得积分10
11秒前
12秒前
阿兹卡班完成签到 ,获得积分10
13秒前
会飞的姚二狗完成签到,获得积分10
14秒前
狂野映波发布了新的文献求助10
14秒前
张婉婉完成签到,获得积分20
19秒前
20秒前
24秒前
玛奇玛完成签到 ,获得积分10
24秒前
LI发布了新的文献求助10
26秒前
昔我往矣完成签到 ,获得积分10
28秒前
所所应助超级的丸子采纳,获得10
31秒前
务实觅松完成签到 ,获得积分10
33秒前
可爱的日记本完成签到 ,获得积分10
34秒前
简单的莫言完成签到,获得积分10
34秒前
38秒前
酷波er应助星star采纳,获得10
40秒前
oleskarabach完成签到,获得积分20
41秒前
42秒前
Liux发布了新的文献求助10
43秒前
年轻薯片完成签到 ,获得积分10
43秒前
11111发布了新的文献求助10
45秒前
45秒前
47秒前
49秒前
桐桐应助YukiXu采纳,获得10
49秒前
科研通AI6.2应助YukiXu采纳,获得10
49秒前
思源应助YukiXu采纳,获得10
49秒前
完美世界应助YukiXu采纳,获得10
50秒前
科研通AI6.1应助YukiXu采纳,获得10
50秒前
科研通AI6.2应助YukiXu采纳,获得10
50秒前
我是老大应助YukiXu采纳,获得10
50秒前
彭于晏应助YukiXu采纳,获得10
50秒前
FashionBoy应助YukiXu采纳,获得10
50秒前
科研通AI6.2应助YukiXu采纳,获得10
50秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Kinesiophobia : a new view of chronic pain behavior 2000
Research for Social Workers 1000
Mastering New Drug Applications: A Step-by-Step Guide (Mastering the FDA Approval Process Book 1) 800
The Social Psychology of Citizenship 600
Signals, Systems, and Signal Processing 510
Discrete-Time Signals and Systems 510
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 计算机科学 有机化学 物理 生物化学 纳米技术 复合材料 内科学 化学工程 人工智能 催化作用 遗传学 数学 基因 量子力学 物理化学
热门帖子
关注 科研通微信公众号,转发送积分 5914401
求助须知:如何正确求助?哪些是违规求助? 6847829
关于积分的说明 15791495
捐赠科研通 5039555
什么是DOI,文献DOI怎么找? 2712832
邀请新用户注册赠送积分活动 1663629
关于科研通互助平台的介绍 1604673